Allosteric inhibitor of PGAM1 identified for NSCLC

DISEASE CATEGORY: Cancer

INDICATION: Non-small cell lung cancer (NSCLC)

A benzenesulfonamide-based allosteric inhibitor of PGAM1, given alone or in combination with the EGFR inhibitor

Read the full 229 word article

User Sign In